MIF and breast carcinoma: Studies have demonstrated that macrophage migration inhibitory factor (MIF), secreted by breast cancer stem cells (BCSCs), activates the WNT/β-catenin signaling pathway to upregulate c-MYC-mediated expression of aldolase C, thereby promoting glycolytic metabolism in tumor cells.